Severe rhabdomyolysis in an infant due to fatty acid oxidation disorder: a case report

Amelie Krug1, Pascale Perlot2, Aurelie Empain3

  • 1Université Libre de Bruxelles (ULB), Rte de Lennik 808, Anderlecht, 1070, Brussels, Belgium. ameliemskrug@gmail.com.

PubMed

Insights

Carnitine palmitoyltransferase II deficiency, a rare metabolic myopathy, can cause severe rhabdomyolysis in infants. Genetic analysis is crucial for diagnosis, even with normal initial metabolic tests.

Area of Science:

  • Pediatrics
  • Genetics
  • Biochemistry

Background:

  • Rhabdomyolysis, a serious condition with diverse causes, necessitates prompt etiological identification and treatment.
  • Early diagnosis and intervention are critical to mitigate severe consequences of rhabdomyolysis.

Purpose of the Study:

  • To report a case of severe rhabdomyolysis in an infant.
  • To highlight the diagnostic challenges of carnitine palmitoyltransferase II deficiency in early childhood.
  • To emphasize the role of genetic analysis in diagnosing metabolic myopathies.

Main Methods:

  • Case report of a 14-month-old infant presenting with fever, hypotonia, and elevated creatine phosphokinase.
  • Initial metabolic investigations were performed, revealing normal acylcarnitine profiles.
  • Genetic analysis identified a homozygous missense variant in the CPT2 gene (NM_000098.3, c.338C>T, p.[Ser113Leu]).

Main Results:

  • The infant presented with severe rhabdomyolysis and extremely high creatine phosphokinase levels (>100,000 UI/L).
  • Despite normal primary metabolic analyses, genetic testing confirmed Carnitine palmitoyltransferase II deficiency.
  • Prophylactic strategies and genetic counseling were implemented for the patient and family.

Conclusions:

  • Carnitine palmitoyltransferase II deficiency can manifest as severe rhabdomyolysis in infants.
  • Diagnosis can be challenging due to normal initial metabolic screening.
  • Genetic analysis is essential for definitive diagnosis of CPT2 deficiency in infants.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
249
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.9K
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
3.7K
Smooth Endoplasmic Reticulum01:21

Smooth Endoplasmic Reticulum

Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
6.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Pyruvate Oxidation01:15

Pyruvate Oxidation

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
161.9K